Recommendations Concerning the Therapeutic Approach to Immunocompromised Children With Tuberculosis.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Clinical Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinthera.2015.10.012PMID 26548321
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disseminated tuberculosis in 2 children with inflammatory bowel disease receiving infliximab.

  2014cited by this paper
• Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendations.

  2014cited by this paper
• Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

  2013cited by this paper
• Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya.

  2013cited by this paper
• Effects of rifampin-based antituberculosis therapy on plasma efavirenz concentrations in children vary by CYP2B6 genotype

  2013cited by this paper
• Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level.

  2013cited by this paper
• Reduction in Mycobacterial Disease Among HIV-infected Children in the Highly Active Antiretroviral Therapy Era (1997–2008)

  2012cited by this paper
• QuantiFERON®-TB Gold In-Tube Performance for Diagnosing Active Tuberculosis in Children and Adults in a High Burden Setting

  2012cited by this paper
• Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment

  2012cited by this paper
• Tuberculosis in Pediatric Solid Organ and Hematopoietic Stem Cell Transplant Recipients

  2012cited by this paper
• Mycobacterium tuberculosis pneumonia and bacteremia after allogeneic hematopoietic stem cell transplant: report of an instructive pediatric case.

  2012cited by this paper
• TB and HIV Therapeutics: Pharmacology Research Priorities

  2012cited by this paper
• Neurological manifestations of TB-IRIS: a report of 4 children.

  2012cited by this paper
• Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent

  2011cited by this paper
• Impact of tuberculosis cotreatment on viral suppression rates among HIV-positive children initiating HAART

  2011cited by this paper
• Antiretroviral Therapy Outcomes in HIV-Infected Children after Adjusting Protease Inhibitor Dosing during Tuberculosis Treatment

  2011cited by this paper
• TB and HIV in children - advances in prevention and management.

  2011cited by this paper
• Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment

  2010cited by this paper
• Scottish Intercollegiate Guidelines Network

  2010cited by this paper
• Human Immunodeficiency Virus and Tuberculosis Coinfection in Children: Challenges in Diagnosis and Treatment

  2010cited by this paper
• Initial response to protease-inhibitor-based antiretroviral therapy among children less than 2 years of age in South Africa: effect of cotreatment for tuberculosis.

  2010cited by this paper
• Interferon-gamma release assays for the detection of Mycobacterium tuberculosis infection in children with cancer.

  2010cited by this paper
• Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children

  2010cited by this paper
• The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement

  2010cited by this paper
• Infections in acute myeloid leukemia: an analysis of 382 febrile episodes

  2010cited by this paper
• Anti-retroviral therapy reduces incident tuberculosis in HIV-infected children.

  2009cited by this paper
• Ethionamide cross- and co-resistance in children with isoniazid-resistant tuberculosis.

  2009cited by this paper
• Detection of tuberculosis in HIV-infected children using an enzyme-linked immunospot assay

  2009cited by this paper
• High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies.

  2009cited by this paper
• Effect of Rifampicin on Efavirenz Pharmacokinetics in HIV-Infected Children With Tuberculosis

  2009cited by this paper
• The Likelihood of an Indeterminate Test Result from a Whole-Blood Interferon-&ggr; Release Assay for the Diagnosis of Mycobacterium tuberculosis Infection in Children Correlates With Age and Immune Status

  2009cited by this paper
• Extensively drug resistant tuberculosis in a 7-year-old child with interferon-&ggr; and interleukin-12 deficiency

  2009cited by this paper
• Gamma Interferon Release Assays for Diagnosis of Tuberculosis Infection in Immune-Compromised Children in a Country in Which the Prevalence of Tuberculosis Is Low

  2009cited by this paper
• The Clinical Burden of Tuberculosis Among Human Immunodeficiency Virus-Infected Children in Western Kenya and the Impact of Combination Antiretroviral Treatment

  2009cited by this paper
• IFN-γ release assays in tuberculosis management in selected high-risk populations

  2009cited by this paper
• Adverse events to antituberculosis therapy: influence of HIV and antiretroviral drugs

  2009cited by this paper
• Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia

  2009cited by this paper
• Disseminated tuberculous myositis in a child with acute myelogenous leukemia.

  2009cited by this paper
• Presentation, diagnosis and management of tuberculosis in HIV‐infected children in the UK

  2008cited by this paper
• Commercial Nucleic-Acid Amplification Tests for Diagnosis of Pulmonary Tuberculosis in Respiratory Specimens: Meta-Analysis and Meta-Regression

  2008cited by this paper
• Clinical presentation and outcome of Tuberculosis in Human Immunodeficiency Virus infected children on anti-retroviral therapy

  2008cited by this paper
• Diagnostic and management challenges for childhood tuberculosis in the era of HIV.

  2007cited by this paper
• Use of DNA tests for human Papillomavirus infection by US clinicians, 2004.

  2007cited by this paper
• Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART

  2007cited by this paper
• Clinical Presentation, treatment outcome and survival among the HIV infected children with culture confirmed tuberculosis.

  2007cited by this paper
• A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment.

  2007cited by this paper
• Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.

  2007cited by this paper
• Tuberculosis and human immunodeficiency virus co-infection in children: management challenges.

  2007cited by this paper
• Agreement between clinical scoring systems used for the diagnosis of pediatric tuberculosis in the HIV era.

  2007cited by this paper
• Immune Reconstitution Syndrome After Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Thai Children

  2006cited by this paper
• Clinical characteristics and treatment responses of tuberculosis in patients with malignancy receiving anticancer chemotherapy.

  2005cited by this paper
• Nosocomial transmission of Mycobacterium tuberculosis in a children's hospital.

  2005cited by this paper
• Severe CD8 deficiency in a child with miliary tuberculosis.

  2005cited by this paper
• Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor.

  2004cited by this paper
• Pulmonary Tuberculosis in a Child Receiving Intensive Chemotherapy for Acute Myeloblastic Leukemia

  2004cited by this paper
• Risk of development of tuberculosis in HIV-infected patients.

  2000cited by this paper
• Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City

  2000cited by this paper
• Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain. Spanish Transplantation Infection Study Group, GESITRA.

  1997cited by this paper
• Immunologic disorders in infants and children

  1973cited by this paper

• Tuberculosis in Children With Primary Immunodeficiencies: A 13‐Year Retrospective Experience

  2026cites this paper
• Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.

  2024cites this paper
• Pediatric tuberculosis in Mexico: A retrospective analysis of 100 patients

  2024cites this paper
• Factores de predicción de inmunodeficiencias en niños con tuberculosis: experiencia de un hospital de tercer nivel en México

  2022cites this paper
• Treating children with tuberculosis: new weapons for an old enemy

  2019cites this paper
• Re : “ Mycobacterial Disease in Immunocompromised Children in a High Endemic Area ” The Pediatric Infectious Disease

  2018cites this paper
• Mycobacterial Disease in Immunocompromised Children in a High Endemic Area.

  2018cites this paper
• Re: "Mycobacterial Disease in Immunocompromised Children in a High Endemic Area".

  2018cites this paper
• Comparison of methods and samples used in the diagnosis of childhood PTB and characterization of mycobacterium tuberculosis isolates

  2018cites this paper
• NeuroAIDS in children.

  2018cites this paper